Market Overview and Dynamics
The Europe brain cancer diagnostics market is projected to grow from US$ 207.5 million in 2021 to US$ 601.0 million by 2028, registering a robust CAGR of 16.4% during the forecast period. This significant growth is driven by advancements in artificial intelligence (AI) and its integration with diagnostic imaging technologies.

?Download Full PDF Sample Copy of Market Report @
https://wwcw.businessmarketinsights.com/sample/TIPRE00025898

AI, particularly deep learning—a subset of AI using convolutional neural networks—enables computers to perform complex tasks such as image analysis by recognizing patterns within data. Researchers are increasingly combining AI with Stimulated Raman Histology (SRH) imaging to improve brain tumor diagnostics. By training AI algorithms on SRH-generated images of brain tumor tissues, the diagnostic process becomes faster and more precise. This collaboration allows AI to complement the expertise of pathologists, improving diagnostic accuracy in challenging cases.

Despite being emerging technologies, SRH and AI are gaining traction in surgical environments. Surgeons can now more accurately distinguish tumor tissue from healthy brain tissue in real time, thereby enhancing surgical outcomes. As the technology matures, integrating AI-driven tools into clinical practice presents both challenges and opportunities for improved patient care.

Key Market Segments

• By Diagnostic Type: The imaging test segment held the largest share of the Europe brain cancer diagnostics market in 2020, driven by the growing reliance on advanced imaging techniques for accurate diagnosis.
• By Cancer Type: Glioblastoma multiforme emerged as the dominant segment in 2020, owing to its aggressive nature and high demand for rapid diagnostic solutions.
• By End User: Hospitals accounted for the largest market share in 2020, reflecting their critical role in providing comprehensive diagnostic and treatment services for brain cancer patients.

Market Introduction

Brain cancers are caused due to extracellular growth of the cells in the brain that causes tumors. The tumor includes primary brain tumors and secondary brain tumors. Primary brain tumors are formed in the brain and do not spread to other body parts, whereas secondary tumors, also known as metastases, are those cancers that began in another part of the body.  Brain tumors are categorized into 40 major types that are further classified into two major groups, including benign, i.e., slow-growing and have less possibility to spread, and malignant, i.e., cancerous, and more likely to spread.

Thus, the increase in prevalence of brain cancer is expected to create a significant demand for brain cancer diagnostics in the coming years, which is further anticipated to drive the brain cancer diagnostics market.

Patients with cancer have been negatively impacted during the COVID-19 pandemic, as many of these individuals may be immunosuppressed and of older age. Additionally, cancer follow-up or imaging appointments have been delayed in many clinics around the world. Postponement of routine screening examinations will result in delays in new cancer diagnoses. Clinics are continuing to monitor and adapt their appointment schedules based on local outbreaks of COVID-19. Studies on COVID-19 in patients with cancer are limited, but consistently indicate that this population is at risk for more severe COVID-19 illness. Data from recent studies also suggest that pediatric patients with cancer have a lower risk of severe COVID-19 illness compared with adults. Certain features of SARS-CoV-2 infection detected by lung, brain, and gastrointestinal imaging may confound radiologists’ interpretation of cancer diagnosis, staging, and treatment response. Lastly, as clinics begin to reopen for routine appointments, protocols have been put in place to reduce SARS-CoV-2 exposure to patients during their visits. This review details different perspectives on the impact of the COVID-19 pandemic on patients with cancer and on cancer imaging.

Strategic Insights: Europe Brain Cancer Diagnostics Market

Strategic insights into the Europe brain cancer diagnostics market deliver a comprehensive, data-driven analysis of the evolving industry landscape. These insights examine current trends, leading market players, and regional dynamics to uncover actionable opportunities. By leveraging advanced data analytics, stakeholders—including investors, manufacturers, and healthcare providers—can identify underserved market segments, craft distinct value propositions, and stay ahead of emerging shifts in demand and technology.

With a strong emphasis on future-oriented strategies, these insights enable industry participants to anticipate change, reduce risk, and make well-informed decisions that enhance competitiveness and long-term profitability. In a rapidly advancing field like brain cancer diagnostics, such strategic intelligence is critical to driving innovation, capturing market share, and achieving sustainable growth across Europe.

Market leaders and key company profiles

  Thermo Fisher Scientific Inc.

  Siemens Healthineers A

  GE Healthcare

  Biocept, Inc.

  Koninklijke Philips N.V

  Canon Medical Systems

  Hitachi, Ltd.

  Neusoft Medical Systems

Europe Brain Cancer Diagnostics Regional Insights

The geographic scope of the Europe Brain Cancer Diagnostics refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics Semiconductor; Aerospace Défense; Automotive Transportation; Energy Power; Healthcare; Manufacturing Construction; Food Beverages; Chemicals Materials; and Technology, Media, Telecommunications

Author's Bio
Akshay
Senior Market Research Expert at Business Market Insights